Cytoplasmic BCR-ABL protein is associated with the development of CML via activation of multiple proliferative and anti-apoptotic signaling pathways causing deregulated cell growth [5]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.